February 27, 2014Open Access

Sphingosine Kinase 1 and Cancer: A Systematic Review and Meta-Analysis

Key Points

Key points are not available for this paper at this time.

Abstract

SK1 positivity and high expression were significantly associated with cancer and a shorter 5-year and overall survival. SK1 positivity rates vary tremendously among the cancer types. It is necessary to further explore whether SK1 might be a predictive biomarker of outcomes in cancer patients.

Bookmark

View Full Paper

Cite This Study

Zhang et al. (Thu,) studied this question.

synapsesocial.com/papers/69dd63b98557d5ab8f40d6c1 https://doi.org/https://doi.org/10.1371/journal.pone.0090362

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sphingosine in apoptosis signaling2002 · 328 citations
2Sphingosine Kinase-1 Expression Correlates With Poor Survival of Patients With Glioblastoma Multiforme: Roles of Sphingosine Kinase Isoforms in Growth of Glioblastoma Cell Lines2005 · 327 citations
3Sphingolipid players in the leukemia arena2006 · 18 citations
4Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens2010 · 85 citations
5Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition2010 · 46 citations

Bookmark

View Full Paper